Gala Health lands at #8 on our ranking with an Editors' Rating of 82/100. If it isn't the right fit, here are the strongest alternatives for a family's GLP-1 care — scored on the same six-factor rubric of family-budget value, clinical oversight, price, access, support and fair cancellation.
Our #1 pick
Ranked #1 · Grade A
CoreAge Rx
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
A coaching-first program that treats weight as a whole-life project rather than a monthly refill — one flat price on both molecules, plus the behavior support a prescription alone never gives you. Whether that's a lifeline or one more app pinging you at bath time is the honest question.
The closest thing on this masthead to an actual obesity-medicine clinic online — a board-certified physician and a registered dietitian on your case, and a real effort to run treatment through your insurance. You trade a see-it-now price for care that behaves like care.
Through the Hers front door, a mass-market brand actually built around a woman's day — nationwide, app-first, with a semaglutide price you can read before you hand over a card. The depth of care is lighter than the marketing implies, but few names are this easy to start with.
A nationwide, physician-led program that does the un-glamorous thing well: it posts a monthly semaglutide price and puts a licensed clinician between you and the prescription. Not the warmest experience on the board, but honest and easy to plan around.
The best-funded option on the board: real brand-name Wegovy and Zepbound access, serious insurance muscle, and an app that rarely breaks — with the catch that its compounded pricing stays behind the intake until you've handed over your history.
A year-long metabolic program that treats the medication as one lever and intensive human coaching as the other — insurance-forward, brand-capable, and serious about the behavior change trials never prescribe. It asks for commitment the same way it asks your insurer to pay.
The budget line on this masthead, and an honest one: some of the lowest flat, all-dose compounded pricing we track — provided you read the annual-prepay footnote before the headline number seduces you.
We keep Direct Meds on the masthead for one reason — full disclosure — and against it we file a 2025 FDA warning letter and a wall of billing complaints. The sublingual option is real; so is the cancellation risk.
Outbound links here may be affiliate links that earn the masthead a fee at no cost to you; they never change a provider's Editors' Rating. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.